Innovative medicine capsule with human and digital elements merging

8 Ways Teva is Accelerating Healthcare Innovation

Teva Pharmaceuticals is leveraging artificial intelligence (AI) and digital innovation at the crossroads of science, technology, and patient care to transform the future of healthcare.

Discover more

Woman on plane checking for pet updates before take-off

Traveling with Schizophrenia: Essential Considerations Before I Go

Traveling with schizophrenia calls for thoughtful preparation. Lesley McCuaig outlines seven challenges she’s faced, including temporary symptom increases and adjusting to new routines.

Discover more

Press Releases

June 26, 2025

Teva Releases Q2 2025 Aide Memoire

June 25, 2025

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

June 23, 2025

Migraine

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

June 16, 2025

Immuno-Oncology

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

June 3, 2025

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

June 3, 2025

Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement

May 31, 2025

Movement Disorders

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

May 31, 2025

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date

May 29, 2025

Innovation

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

May 27, 2025

Innovation

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Healthy Future: Sustainability at Teva

Teva scientists in Sydney, Australia working in the lab

Teva's Healthy Future Report: Creating the Future We Want to See

Our latest Healthy Future Report shows the steps Teva is taking for the health of people, the planet and our business.

View the report now

Take a closer look at what we do

A man with curly hair and a beard smiles warmly while holding a white mug. Soft, colorful hanging lights create a relaxed, cheerful atmosphere.

Explore Our Innovative Therapeutic Areas

Discover more about Innovative Therapeutic Areas

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

Discover more about Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

Spreading HOPE: How Teva is improving access to medicines across the globe

Eric Hughes, Chief Medical Officer giving a speech

How Can We Use AI to Make Medicines More Efficiently?

Discover more

What to know about schizophrenia

Discover more

Complex Generics: Facts, Figures and Who They Benefit

Tools & Resources for Caregivers

Discover more

People discussing why diversity in clinical trials is important

Why Diversity in Clinical Trials is So Important

Discover more

Careers at Teva

Four lab-coated professionals share ideas, emphasizing Teva's commitment to improving health daily.

Make a difference to people's health, every day

Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves

Explore a Teva Career